Complete esophageal stenos is secondary to pepti c stricture in the upp er esophag us is rare. It is, however; a ser ious medical p roblem that may require otolaryngo log ic interventi on because of life-threatening dyspha gia and weight loss. We report the case of an elde rly patient who p resented with an upper esop hagea l stricture, with out the typical sym ptoms ofgastroesophageal reflux disease, that p rogressed to complete esop hageal obstruction despite use ofpro ton pump inhibitors and esophageal dilatati on. Defin itive management of this difficult p roblem required esophagectonty and gas tric pull-up. We discuss the path oph ysiology, clinical presentation, differenti al dia gnosis, and multidisciplin ary man agement of pepti c esophage al stric tures. This case illustrates the difficulty in managing high pepti c strictures.
Introduction
Gastroesophageal reflux disease (GERO) is a co mmon problem , with at least 10% of the U.S. popul ation reporting symptoms of heartburn or acid reflux at least once per week.I Head and neck manife stations and compli cati ons of GERO are commonly see n in a genera l otolaryngo logy practice and may present significant morbidit y. Between 40 and 65% of those who suffer from GERO develop eros ive eso phag itis.' If left untreated, reflux eso phag itis may lead to pept ic esophagea l stricture in 4 to 23% of these patient s. ' Although peptic strictures are common, progression to co mplete eso phage al stenosis in the upper esoph agus occurs rarely. We report the case management of an elderly man with co mplete eso phageal stenosis secondary to pepti c stric ture in the cervical esophag us, which requi red eso phagea l resection and gas tric pull-up. From 
Case report
A 65-year-old African American man was referred to the Otolaryngology-Head and Neck Surgery service forevaluation and management of stricture in the upper esophagus. He is a widower, and had worked as a tile installer for 25 years. His symptoms had started 2 year s previously with dysphagia to solids, progressing to an inability to eat , drink , or swallow his saliva. He reported losing 70 pounds dur ing that time and required a percutaneous endoscopic gas trostomy for alimentation. He denied heartburn , caustic ingestion/ inhalation, history of radiation therapy to the head and neck regi on, otalgia, shortness of breath , hoarseness, feve rs, chill s, night sweats, or aspirin use. He consumed alcohol occasionally and denied a history of tobacco use. However, he had a long history of atypi cal chest pain and epigas tric discomfort. His medical history was significant for major depre ssive disorder with delu sions, unresponsive to an array of medications and electroco nvulsive therapy. Medications on presentation includ ed mirtazapine (an antidepressa nt), haloperidol, cyprohept adine (an appetit e stimulant), and lansopra zole. Initial esophagoduodenoscopy (EGO) by gastroenterologists at an outside instituti on had revealed no significa nt eso phag ea l path ology. Sub sequent EGO evaluations revea led significant reflux esopha gitis and ulcerations progressing to eso phagea l stricture in the upper esophag us. Biopsies in the region of the stricture did not show malignancy. The stricture was managed with dilatations, and lansoprazole 30 mg daily was started.The most recent EGO had been unsuccessful because the scope could not pass beyond the stricture, either from the oropharynx or retrograde throu gh the percutaneous endosco pic gastrostomy.
At the patien t' s initial visit to our service, examination show ed a thin, debilitated elderly man with normal upper airway and cranial nerve finding s. A barium esophagogram showe d co mplete obstruc tion of the upper part of the esoph agus (figure I). On computed tom ography of the chest, the thorax showed a dilated cervical esophagus and no obvious mass compress ing or invol ving it (figure 2). Rigid eso phagosco py revealed a blind eso phageal pouch with a small granulation polyp 2 1 Col from the upper incisors. Biop sy was con sistent with norm al squamo us mucosa, with inflammatory changes in the ep ithelium but no malign ancy. Th e site of this obstructio n was co nsistent with the site of the docum ent ed esophageal stricture.
Becau se this wa s an unu sual locati on for pepti c eso phagea l stricture, we investigated furth er to excl ude othe r known etiolog ies for strict ures . Auto immune disorders such as scle rode rma and sys temic lupu s erythe matos us were excl uded by laboratory studies and clinical ex amination . Serol ogy res ults for human immunod efic ien cy virus were negative. A d iagn osis of GERD-related eso phag ea l obstruction was made, and a guide wire wa s placed with balloon dil atati on of the eso phag us under fluoroscop ic guida nce. Thi s wa s initially successful in creating a sma ll eso phage al lum en , but restenosis qu ickl y occ urred. A transhiatal eso phagectomy with gastric pull-up and feed ing jejunostomy was performed . Pathologic exami nation of the eso phagecto my spec ime n revealed ulcerated mucosa with acute and chro nic inflammation and granulation tiss ue with no evidence o f malignancy.
Since surge ry, the patient has tolerated oral feed ings, has ga ined sig nifica nt weigh t, and has made sig nificant imp rovem ent in his depressive disorder.
Discussion
One of the most significa nt long-standing sequelae of untreated reflux esophagi tis fro m GERD is pepti c eso phageal stricture."Factors predi sposing to stricture form ation are not well understood , bu t studies dem on strate that patients with pepti c stricture are olde r, have reflu x symptoms of longer duration, have an associated eso phageal motil ity disord er, and have sig nifican tly redu ced lower esophageal sp hincter pressures.' Strict ures occ ur whe n eso phag itis progresses to panmural inflammati on . This result s in thickening and sca rring of the invo lved seg me nt, which is usuall y located in the distal eso phag us at the sq uamocolum nar j unction.' Oth er fac tors besid es ex pos ure of the esophageal mucosa to ac id likely co ntribute to the develop men t of erosive esophag itis.' Dysph agia is the most co mmon prese nting symptom in patients with benig n esophage al stricture . A history of typical hear tburn sy mpto ms is presen t in more than 75 % of pati ent s with peptic strict ures .i-' However, olde r patient s are less likel y to report freque nt or severe heartburn , perh ap s because of decreased gas tric ac idity and a decl ine in esophageal se nsit ivity wit h age. ' T he different ial diagn osis for eso phageal strictures is ex tensive and includes pepti c strictures, which co mpr ise 60 to 70 %; esophageal tumors; ca ustic ingestion ; nasogastric tub e trauma; scleroder ma; radiation therapy; infections (e.g ., Candida. tubercul osis);drugs (e.g., doxycycl ine/te tracycl ine, potassium chloride, quinidine, vitami n C); Crohn's d isease ; pill-in duced esophag itis ; and bull ou s de rmatoses such as epider mo lysis bull osa and pemph igus."
Barium eso phagograp hy is the initial d iagn ostic procedure for patient s with GE RD who prese nt with dysphagi a because it has grea ter se nsitivi ty (95 %) tha n endoscopy in detecting strictures. ' Biops ies sho uld be taken at endoscopy and sho uld incl ude tissue bo th fro m proximal ulcerated areas and fro m the depth s of the stricture . In the abse nce of a cle ar history of GE RD, serolog ic testing to excl ude autoim mune etiology is recomm ended. Serum gas tri n levels and salicy late levels arc useful in detecting eso phageal pH studies .' In our e lde rly patient , additional factors besid es GE RD-such as the use of medi cation s that may decrease lower eso phageal sphincter pressur e, disturb ance in eso phageal motility from agin g, and ab sence of the typic al sy mptoms ofheartburn that delayed adequate diagn osis-likely co ntri buted to esophage al ste nos is. Oral medi cati on s that may redu ce lower esophage al sphincter pressure include gro ups of dru gs ca lled nitrates (e.g., isosorbide din itrate), ca lcium-c ha nne l blocker s, di azepam, barbiturates, non steroidal anti-inflammatory dru gs, theoph ylli ne, and nicotin e. Sin ce, prior to his visit to our serv ice, the patient was tried on multiple med icati on s for depression , it is uncert ain which medic ation , if any, might have playe d a part in GE RD and str icture form ation.
Th e main stay o f treatment for pepti c strictures has traditi on ally been mech anical dil atation. Furthe r med ical managem ent incl udes use of H 2-recept or block ers, proton pump inhibitors, and intral esion al stero id injecti ons. Studies have sho wn that agg ressive acid suppressi on with proton pump inhibitors decrea ses the frequ en cy o f pepti c stricture dil atation .'
Eso phageal resection with rec on structi on for peptic strictures is reser ved for strictures that cannot be adequately dilated , rapid rec urrence of a stricture afte r dil atation , or an irreversibl y damaged esophagus with tran smural fibros is a nd ev ide nce of ape ristalsis on man ometry. Recon stru cti on options include seg me ntal resecti on and esophagogastros to my or total esophage ctomy with j ejunal or co lon interp ositi on.
In summary, physicians mu st keep a high index of suspicion for pept ic strictures in patients with complaints of persisten t dy sph agia eve n in the absence of typical sy mptoms of GERD. A multidi sciplinary treatment team that con sists of the otolary ngologist, gastroenterolog ist, and swallo wing therapi st should manage these pati ents once the diagno sis has been established. Early medical treatme nt with proton pump inhibitors, es pecially in elderl y pat ient s who have other predi spo sing facto rs, should be imple mented to prevent stricture pro gression to complete stenos is.
